Stay updated on Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new page revision tag (v3.7.0) was added to the record history, and the previous tag (v3.6.6) was removed, updating the history to reflect the latest version of the page.SummaryDifference0.1%

- Check42 days agoChange DetectedThe study record history shows a new revision, v3.6.6, superseding the previous v3.6.5. This indicates the record was updated to a newer version.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, and the previous revision v3.6.4 was removed. This reflects an update to the record's version history rather than changes to the study content or data.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, reflecting an update to the record. The previous revision v3.6.3 is removed from the visible history.SummaryDifference0.1%

- Check105 days agoChange DetectedThe study record history now shows a new revision entry (v3.6.3) and removes the previous revision (v3.6.1), indicating an update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-CD38 CAR-T in Relapsed/Refractory Multiple Myeloma Clinical Trial page.